International Stem Cell Corp. (ISCO) to Participate in Upcoming Investor Conference
California-based International Stem Cell Corp. announced that Dr. Simon Craw, the company’s Executive Vice President of Business Development, will attend and present at the SeeThru Equity Fall Smallcap & Microcap Conference, to be held at the Cornell Club in midtown Manhattan, New York, on Tuesday, October 2, 2012. International Stem Cell is a biotechnology company focused on therapeutic and research products. The company has developed a powerful new stem cell technology called parthenogenesis that promises to advance the field of regenerative medicine by addressing the problem of immune-rejection. Risk of rejection for stem cell therapeutics is proportional to the degree…